Atlassian uses cookies to improve your browsing experience, perform analytics and research, and conduct advertising. Accept all cookies to indicate that you agree to our use of cookies on your device.
Atlassian uses cookies to improve your browsing experience, perform analytics and research, and conduct advertising. Accept all cookies to indicate that you agree to our use of cookies on your device. Atlassian cookies and tracking notice, (opens new window)
In contrast to Shen, 2007 paper Weisenberger, 2006 identified a smaller set of markers: CACNA1G, IGF2, NEUROG1, RUNX3, SOCS1 and MLH1 as CIMP in colorectal patients. These markers were also confirmed in Hinoue, 2011 paper. In 2006 paper they weren't able to confirm Shen's markers.